Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy

Table 4 Distribution of 334 HIV/HBV co-infected patients on current anti-HBV treatment according to EACS treatment guidelines

	EACS GC regimens		EACS GU regimens
	n	%	n	%
No indication for anti-HIV therapy	30	68.2	14	31.8
Indication for anti-HIV therapy°	202	79.2	53	20.8
Indication for anti-HIV therapy not known^§	2	--	--	--
Cirrhotic/HCC	21	65.6	11	34.4
Total	255	76.6	78	23.4

EACS, European AIDS clinical society; GC, guideline consistent; GU, guideline unlisted; °according to EACS guidelines for HCV co-infection [6], 1 patient with triple HCV co-infection on PEG-IFN was considered as “consistent”; ^§3 patients: 2 on TDF plus LAM/FTC considered as “consistent”, 1 not classifiable.

ISSN: 1756-0500